Pharma & Healthcare
Global Avian Influenza Vaccines Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 01, 25
- ID: 285540
- Pages: 183
- Figures: 184
- Views: 26
In 2024, the global market size of Avian Influenza Vaccines was estimated to be worth US$ 1100 million and is forecast to reach approximately US$ 1592 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.Avian Influenza Vaccines is a kind of vaccine used to prevent infection caused by Avian Influenza bacteria.
The avian influenza vaccines market is driven by the increasing prevalence of avian flu outbreaks, which pose significant threats to both poultry industries and public health. As global poultry consumption rises, the need to protect livestock from highly pathogenic avian influenza strains is critical to maintaining food security and preventing economic losses. Governments and regulatory bodies are increasingly focused on preventing zoonotic transmission, leading to the widespread use of vaccines in poultry farms. Additionally, ongoing advancements in vaccine development, such as more effective and faster-acting vaccines, are further driving market growth.
A major challenge in the avian influenza vaccines market is the high cost and logistical difficulties of mass vaccination programs, especially in large-scale poultry farms or regions with limited veterinary infrastructure. The need for continuous monitoring and re-vaccination due to the evolving nature of avian influenza strains adds to the complexity and cost of vaccine deployment. Additionally, regulatory barriers and varying standards for vaccine approval across different countries can hinder the global distribution of vaccines, limiting market expansion in certain regions.
Global Avian Influenza Vaccines key players include Boehringer Ingelheim, CAHIC, DHN, HVRI, etc. Global top five manufacturers hold a share over 70%. China is the largest market, with a share about 45%. In terms of product, Type H5 is the largest segment, with a share over 70%. And in terms of application, the largest application is Chicken, followed by Duck and Goose, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Avian Influenza Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Avian Influenza Vaccines.
The Avian Influenza Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Avian Influenza Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Avian Influenza Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Boehringer Ingelheim
CAHIC
DHN
HVRI
CEVA
Elanco Animal Health
Zoetis
FATRO
Kyoto Biken
CAVAC
Ringpu Biology
Vaksindo
Sindh Poultry Vaccine Centre
Merck Animal Health
PT Medion Farma Jaya
Avimex Animal Health
JOVAC
Bio-Labs
Pusvetma
IPB-Shigeta
Medion Farma Jaya
Caprifamarindo
Segment by Type
H5+H7 Avian Influenza Vaccines
H9 Avian Influenza Vaccines
Segment by Application
Chicken
Duck & Goose
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Avian Influenza Vaccines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Avian Influenza Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Avian Influenza Vaccines sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.Avian Influenza Vaccines is a kind of vaccine used to prevent infection caused by Avian Influenza bacteria.
The avian influenza vaccines market is driven by the increasing prevalence of avian flu outbreaks, which pose significant threats to both poultry industries and public health. As global poultry consumption rises, the need to protect livestock from highly pathogenic avian influenza strains is critical to maintaining food security and preventing economic losses. Governments and regulatory bodies are increasingly focused on preventing zoonotic transmission, leading to the widespread use of vaccines in poultry farms. Additionally, ongoing advancements in vaccine development, such as more effective and faster-acting vaccines, are further driving market growth.
A major challenge in the avian influenza vaccines market is the high cost and logistical difficulties of mass vaccination programs, especially in large-scale poultry farms or regions with limited veterinary infrastructure. The need for continuous monitoring and re-vaccination due to the evolving nature of avian influenza strains adds to the complexity and cost of vaccine deployment. Additionally, regulatory barriers and varying standards for vaccine approval across different countries can hinder the global distribution of vaccines, limiting market expansion in certain regions.
Global Avian Influenza Vaccines key players include Boehringer Ingelheim, CAHIC, DHN, HVRI, etc. Global top five manufacturers hold a share over 70%. China is the largest market, with a share about 45%. In terms of product, Type H5 is the largest segment, with a share over 70%. And in terms of application, the largest application is Chicken, followed by Duck and Goose, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Avian Influenza Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Avian Influenza Vaccines.
The Avian Influenza Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Avian Influenza Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Avian Influenza Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Boehringer Ingelheim
CAHIC
DHN
HVRI
CEVA
Elanco Animal Health
Zoetis
FATRO
Kyoto Biken
CAVAC
Ringpu Biology
Vaksindo
Sindh Poultry Vaccine Centre
Merck Animal Health
PT Medion Farma Jaya
Avimex Animal Health
JOVAC
Bio-Labs
Pusvetma
IPB-Shigeta
Medion Farma Jaya
Caprifamarindo
Segment by Type
H5+H7 Avian Influenza Vaccines
H9 Avian Influenza Vaccines
Segment by Application
Chicken
Duck & Goose
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Avian Influenza Vaccines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Avian Influenza Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Avian Influenza Vaccines sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
1 Study Coverage
1.1 Avian Influenza Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Avian Influenza Vaccines Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 H5+H7 Avian Influenza Vaccines
1.2.3 H9 Avian Influenza Vaccines
1.3 Market by Application
1.3.1 Global Avian Influenza Vaccines Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Chicken
1.3.3 Duck & Goose
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Avian Influenza Vaccines Market Size Estimates and Forecasts
2.1.1 Global Avian Influenza Vaccines Revenue 2020-2031
2.1.2 Global Avian Influenza Vaccines Sales 2020-2031
2.2 Avian Influenza Vaccines Market Size by Region: 2024 Versus 2031
2.3 Avian Influenza Vaccines Sales by Region (2020-2031)
2.3.1 Global Avian Influenza Vaccines Sales by Region: 2020-2025
2.3.2 Global Avian Influenza Vaccines Sales Forecast by Region (2026-2031)
2.3.3 Global Avian Influenza Vaccines Sales Market Share by Region (2020-2031)
2.4 Avian Influenza Vaccines Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Avian Influenza Vaccines Revenue by Region: 2020-2025
2.4.2 Global Avian Influenza Vaccines Revenue Forecast by Region (2026-2031)
2.4.3 Global Avian Influenza Vaccines Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Avian Influenza Vaccines Sales by Type (2020-2031)
3.1.1.1 Global Avian Influenza Vaccines Sales Volume by Type (2020-2031)
3.1.1.2 Global Avian Influenza Vaccines Sales Market Share by Type (2020-2031)
3.1.2 Global Avian Influenza Vaccines Revenue by Type (2020-2031)
3.1.2.1 Global Avian Influenza Vaccines Revenue by Type (2020-2031)
3.1.2.2 Global Avian Influenza Vaccines Revenue Market Share by Type (2020-2031)
3.1.3 Avian Influenza Vaccines Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Avian Influenza Vaccines Sales by Application (2020-2031)
3.2.1.1 Global Avian Influenza Vaccines Sales Volume by Application (2020-2031)
3.2.1.2 Global Avian Influenza Vaccines Sales Market Share by Application (2020-2031)
3.2.2 Global Avian Influenza Vaccines Revenue by Application (2020-2031)
3.2.2.1 Global Avian Influenza Vaccines Revenue by Application (2020-2031)
3.2.2.2 Global Avian Influenza Vaccines Revenue Market Share by Application (2020-2031)
3.2.3 Avian Influenza Vaccines Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 H5+H7 Avian Influenza Vaccines of Avian Influenza Vaccines Revenue Market Share by Application
3.3.2 H9 Avian Influenza Vaccines of Avian Influenza Vaccines Revenue Market Share by Application
4 Global Avian Influenza Vaccines by Manufacturers
4.1 Global Top Avian Influenza Vaccines Manufacturers by Sales (2020-2025)
4.1.1 Global Avian Influenza Vaccines Sales by Manufacturer (2020-2025)
4.1.2 Global Avian Influenza Vaccines Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Avian Influenza Vaccines Manufacturers by Revenue (2020-2025)
4.2.1 Global Avian Influenza Vaccines Revenue by Manufacturer (2020-2025)
4.2.2 Global Avian Influenza Vaccines Revenue Share by Manufacturer (2020-2025)
4.3 Global Avian Influenza Vaccines Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Avian Influenza Vaccines Manufacturers Covered: Ranking by Revenue
4.4.2 Global Avian Influenza Vaccines Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Avian Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Avian Influenza Vaccines Manufacturing Base Distribution, Product Type
4.5.1 Avian Influenza Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Avian Influenza Vaccines Market
4.5.3 Manufacturers Avian Influenza Vaccines Product Type and Application
4.5.4 H5+H7 Avian Influenza Vaccines Market Sales of Avian Influenza Vaccines by Manufacturer
4.5.5 H9 Avian Influenza Vaccines Market Sales of Avian Influenza Vaccines by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Boehringer Ingelheim
5.1.1 Boehringer Ingelheim Company Information
5.1.2 Boehringer Ingelheim Description, Business Overview
5.1.3 Boehringer Ingelheim Avian Influenza Vaccines Products Offered
5.1.4 Boehringer Ingelheim Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Boehringer Ingelheim Avian Influenza Vaccines Sales by Product in 2024
5.1.6 Boehringer Ingelheim Avian Influenza Vaccines Sales by Application in 2024
5.1.7 Boehringer Ingelheim Avian Influenza Vaccines Sales by Geographic Area in 2024
5.1.8 Boehringer Ingelheim Recent Developments
5.2 CAHIC
5.2.1 CAHIC Company Information
5.2.2 CAHIC Description, Business Overview
5.2.3 CAHIC Avian Influenza Vaccines Products Offered
5.2.4 CAHIC Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.2.5 CAHIC Avian Influenza Vaccines Sales by Product in 2024
5.2.6 CAHIC Avian Influenza Vaccines Sales by Application in 2024
5.2.7 CAHIC Avian Influenza Vaccines Sales by Geographic Area in 2024
5.2.8 CAHIC Recent Developments
5.3 DHN
5.3.1 DHN Company Information
5.3.2 DHN Description, Business Overview
5.3.3 DHN Avian Influenza Vaccines Products Offered
5.3.4 DHN Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.3.5 DHN Avian Influenza Vaccines Sales by Product in 2024
5.3.6 DHN Avian Influenza Vaccines Sales by Application in 2024
5.3.7 DHN Avian Influenza Vaccines Sales by Geographic Area in 2024
5.3.8 DHN Recent Developments
5.4 HVRI
5.4.1 HVRI Company Information
5.4.2 HVRI Description, Business Overview
5.4.3 HVRI Avian Influenza Vaccines Products Offered
5.4.4 HVRI Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.4.5 HVRI Avian Influenza Vaccines Sales by Product in 2024
5.4.6 HVRI Avian Influenza Vaccines Sales by Application in 2024
5.4.7 HVRI Avian Influenza Vaccines Sales by Geographic Area in 2024
5.4.8 HVRI Recent Developments
5.5 CEVA
5.5.1 CEVA Company Information
5.5.2 CEVA Description, Business Overview
5.5.3 CEVA Avian Influenza Vaccines Products Offered
5.5.4 CEVA Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.5.5 CEVA Avian Influenza Vaccines Sales by Product in 2024
5.5.6 CEVA Avian Influenza Vaccines Sales by Application in 2024
5.5.7 CEVA Avian Influenza Vaccines Sales by Geographic Area in 2024
5.5.8 CEVA Recent Developments
5.6 Elanco Animal Health
5.6.1 Elanco Animal Health Company Information
5.6.2 Elanco Animal Health Description, Business Overview
5.6.3 Elanco Animal Health Avian Influenza Vaccines Products Offered
5.6.4 Elanco Animal Health Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Elanco Animal Health Avian Influenza Vaccines Sales by Product in 2024
5.6.6 Elanco Animal Health Avian Influenza Vaccines Sales by Application in 2024
5.6.7 Elanco Animal Health Avian Influenza Vaccines Sales by Geographic Area in 2024
5.6.8 Elanco Animal Health Recent Developments
5.7 Zoetis
5.7.1 Zoetis Company Information
5.7.2 Zoetis Description, Business Overview
5.7.3 Zoetis Avian Influenza Vaccines Products Offered
5.7.4 Zoetis Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Zoetis Avian Influenza Vaccines Sales by Product in 2024
5.7.6 Zoetis Avian Influenza Vaccines Sales by Application in 2024
5.7.7 Zoetis Avian Influenza Vaccines Sales by Geographic Area in 2024
5.7.8 Zoetis Recent Developments
5.8 FATRO
5.8.1 FATRO Company Information
5.8.2 FATRO Description, Business Overview
5.8.3 FATRO Avian Influenza Vaccines Products Offered
5.8.4 FATRO Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.8.5 FATRO Avian Influenza Vaccines Sales by Product in 2024
5.8.6 FATRO Avian Influenza Vaccines Sales by Application in 2024
5.8.7 FATRO Avian Influenza Vaccines Sales by Geographic Area in 2024
5.8.8 FATRO Recent Developments
5.9 Kyoto Biken
5.9.1 Kyoto Biken Company Information
5.9.2 Kyoto Biken Description, Business Overview
5.9.3 Kyoto Biken Avian Influenza Vaccines Products Offered
5.9.4 Kyoto Biken Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Kyoto Biken Avian Influenza Vaccines Sales by Product in 2024
5.9.6 Kyoto Biken Avian Influenza Vaccines Sales by Application in 2024
5.9.7 Kyoto Biken Avian Influenza Vaccines Sales by Geographic Area in 2024
5.9.8 Kyoto Biken Recent Developments
5.10 CAVAC
5.10.1 CAVAC Company Information
5.10.2 CAVAC Description, Business Overview
5.10.3 CAVAC Avian Influenza Vaccines Products Offered
5.10.4 CAVAC Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.10.5 CAVAC Avian Influenza Vaccines Sales by Product in 2024
5.10.6 CAVAC Avian Influenza Vaccines Sales by Application in 2024
5.10.7 CAVAC Avian Influenza Vaccines Sales by Geographic Area in 2024
5.10.8 CAVAC Recent Developments
5.11 Ringpu Biology
5.11.1 Ringpu Biology Company Information
5.11.2 Ringpu Biology Description, Business Overview
5.11.3 Ringpu Biology Avian Influenza Vaccines Products Offered
5.11.4 Ringpu Biology Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Ringpu Biology Avian Influenza Vaccines Sales by Product in 2024
5.11.6 Ringpu Biology Avian Influenza Vaccines Sales by Application in 2024
5.11.7 Ringpu Biology Avian Influenza Vaccines Sales by Geographic Area in 2024
5.11.8 Ringpu Biology Recent Developments
5.12 Vaksindo
5.12.1 Vaksindo Company Information
5.12.2 Vaksindo Description, Business Overview
5.12.3 Vaksindo Avian Influenza Vaccines Products Offered
5.12.4 Vaksindo Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Vaksindo Avian Influenza Vaccines Sales by Product in 2024
5.12.6 Vaksindo Avian Influenza Vaccines Sales by Application in 2024
5.12.7 Vaksindo Avian Influenza Vaccines Sales by Geographic Area in 2024
5.12.8 Vaksindo Recent Developments
5.13 Sindh Poultry Vaccine Centre
5.13.1 Sindh Poultry Vaccine Centre Company Information
5.13.2 Sindh Poultry Vaccine Centre Description, Business Overview
5.13.3 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Products Offered
5.13.4 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.13.5 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales by Product in 2024
5.13.6 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales by Application in 2024
5.13.7 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales by Geographic Area in 2024
5.13.8 Sindh Poultry Vaccine Centre Recent Developments
5.14 Merck Animal Health
5.14.1 Merck Animal Health Company Information
5.14.2 Merck Animal Health Description, Business Overview
5.14.3 Merck Animal Health Avian Influenza Vaccines Products Offered
5.14.4 Merck Animal Health Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.14.5 Merck Animal Health Avian Influenza Vaccines Sales by Product in 2024
5.14.6 Merck Animal Health Avian Influenza Vaccines Sales by Application in 2024
5.14.7 Merck Animal Health Avian Influenza Vaccines Sales by Geographic Area in 2024
5.14.8 Merck Animal Health Recent Developments
5.15 PT Medion Farma Jaya
5.15.1 PT Medion Farma Jaya Company Information
5.15.2 PT Medion Farma Jaya Description, Business Overview
5.15.3 PT Medion Farma Jaya Avian Influenza Vaccines Products Offered
5.15.4 PT Medion Farma Jaya Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.15.5 PT Medion Farma Jaya Avian Influenza Vaccines Sales by Product in 2024
5.15.6 PT Medion Farma Jaya Avian Influenza Vaccines Sales by Application in 2024
5.15.7 PT Medion Farma Jaya Avian Influenza Vaccines Sales by Geographic Area in 2024
5.15.8 PT Medion Farma Jaya Recent Developments
5.16 Avimex Animal Health
5.16.1 Avimex Animal Health Company Information
5.16.2 Avimex Animal Health Description, Business Overview
5.16.3 Avimex Animal Health Avian Influenza Vaccines Products Offered
5.16.4 Avimex Animal Health Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.16.5 Avimex Animal Health Avian Influenza Vaccines Sales by Product in 2024
5.16.6 Avimex Animal Health Avian Influenza Vaccines Sales by Application in 2024
5.16.7 Avimex Animal Health Avian Influenza Vaccines Sales by Geographic Area in 2024
5.16.8 Avimex Animal Health Recent Developments
5.17 JOVAC
5.17.1 JOVAC Company Information
5.17.2 JOVAC Description, Business Overview
5.17.3 JOVAC Avian Influenza Vaccines Products Offered
5.17.4 JOVAC Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.17.5 JOVAC Avian Influenza Vaccines Sales by Product in 2024
5.17.6 JOVAC Avian Influenza Vaccines Sales by Application in 2024
5.17.7 JOVAC Avian Influenza Vaccines Sales by Geographic Area in 2024
5.17.8 JOVAC Recent Developments
5.18 Bio-Labs
5.18.1 Bio-Labs Company Information
5.18.2 Bio-Labs Description, Business Overview
5.18.3 Bio-Labs Avian Influenza Vaccines Products Offered
5.18.4 Bio-Labs Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.18.5 Bio-Labs Avian Influenza Vaccines Sales by Product in 2024
5.18.6 Bio-Labs Avian Influenza Vaccines Sales by Application in 2024
5.18.7 Bio-Labs Avian Influenza Vaccines Sales by Geographic Area in 2024
5.18.8 Bio-Labs Recent Developments
5.19 Pusvetma
5.19.1 Pusvetma Company Information
5.19.2 Pusvetma Description, Business Overview
5.19.3 Pusvetma Avian Influenza Vaccines Products Offered
5.19.4 Pusvetma Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.19.5 Pusvetma Avian Influenza Vaccines Sales by Product in 2024
5.19.6 Pusvetma Avian Influenza Vaccines Sales by Application in 2024
5.19.7 Pusvetma Avian Influenza Vaccines Sales by Geographic Area in 2024
5.19.8 Pusvetma Recent Developments
5.20 IPB-Shigeta
5.20.1 IPB-Shigeta Company Information
5.20.2 IPB-Shigeta Description, Business Overview
5.20.3 IPB-Shigeta Avian Influenza Vaccines Products Offered
5.20.4 IPB-Shigeta Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.20.5 IPB-Shigeta Avian Influenza Vaccines Sales by Product in 2024
5.20.6 IPB-Shigeta Avian Influenza Vaccines Sales by Application in 2024
5.20.7 IPB-Shigeta Avian Influenza Vaccines Sales by Geographic Area in 2024
5.20.8 IPB-Shigeta Recent Developments
5.21 Medion Farma Jaya
5.21.1 Medion Farma Jaya Company Information
5.21.2 Medion Farma Jaya Description, Business Overview
5.21.3 Medion Farma Jaya Avian Influenza Vaccines Products Offered
5.21.4 Medion Farma Jaya Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.21.5 Medion Farma Jaya Avian Influenza Vaccines Sales by Product in 2024
5.21.6 Medion Farma Jaya Avian Influenza Vaccines Sales by Application in 2024
5.21.7 Medion Farma Jaya Avian Influenza Vaccines Sales by Geographic Area in 2024
5.21.8 Medion Farma Jaya Recent Developments
5.22 Caprifamarindo
5.22.1 Caprifamarindo Company Information
5.22.2 Caprifamarindo Description, Business Overview
5.22.3 Caprifamarindo Avian Influenza Vaccines Products Offered
5.22.4 Caprifamarindo Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.22.5 Caprifamarindo Avian Influenza Vaccines Sales by Product in 2024
5.22.6 Caprifamarindo Avian Influenza Vaccines Sales by Application in 2024
5.22.7 Caprifamarindo Avian Influenza Vaccines Sales by Geographic Area in 2024
5.22.8 Caprifamarindo Recent Developments
6 North America
6.1 North America Avian Influenza Vaccines Market Size YoY Growth 2020-2031
6.2 North America Avian Influenza Vaccines Market Facts & Figures by Country
6.2.1 North America Avian Influenza Vaccines Sales by Country (2020-2031)
6.2.2 North America Avian Influenza Vaccines Revenue by Country (2020-2031)
6.3 North America Avian Influenza Vaccines Sales by Type (2020-2025)
6.4 North America Avian Influenza Vaccines Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Avian Influenza Vaccines Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Avian Influenza Vaccines Market Facts & Figures by Region
7.2.1 Asia-Pacific Avian Influenza Vaccines Sales by Region (2020-2031)
7.2.2 Asia-Pacific Avian Influenza Vaccines Revenue by Region (2020-2031)
7.3 Asia-Pacific Avian Influenza Vaccines Sales by Type (2020-2025)
7.4 Asia-Pacific Avian Influenza Vaccines Sales by Application (2020-2025)
8 Europe
8.1 Europe Avian Influenza Vaccines Market Size YoY Growth 2020-2031
8.2 Europe Avian Influenza Vaccines Market Facts & Figures by Country
8.2.1 Europe Avian Influenza Vaccines Sales by Country (2020-2031)
8.2.2 Europe Avian Influenza Vaccines Revenue by Country (2020-2031)
8.3 Europe Avian Influenza Vaccines Sales by Type (2020-2025)
8.4 Europe Avian Influenza Vaccines Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Avian Influenza Vaccines Market Size YoY Growth 2020-2031
9.2 Latin America Avian Influenza Vaccines Market Facts & Figures by Country
9.2.1 Latin America Avian Influenza Vaccines Sales by Country (2020-2031)
9.2.2 Latin America Avian Influenza Vaccines Revenue by Country (2020-2031)
9.3 Latin America Avian Influenza Vaccines Sales by Type (2020-2025)
9.4 Latin America Avian Influenza Vaccines Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Avian Influenza Vaccines Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Avian Influenza Vaccines Market Facts & Figures by Country
10.2.1 Middle East and Africa Avian Influenza Vaccines Sales by Country (2020-2031)
10.2.2 Middle East and Africa Avian Influenza Vaccines Revenue by Country (2020-2031)
10.3 Middle East and Africa Avian Influenza Vaccines Sales by Type (2020-2025)
10.4 Middle East and Africa Avian Influenza Vaccines Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Avian Influenza Vaccines Supply Chain Analysis
11.2 Avian Influenza Vaccines Key Raw Materials and Upstream Suppliers
11.3 Avian Influenza Vaccines Clients Analysis
11.4 Avian Influenza Vaccines Sales Channel and Sales Model Analysis
11.4.1 Avian Influenza Vaccines Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Avian Influenza Vaccines Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Avian Influenza Vaccines Distributors
12 Avian Influenza Vaccines Market Dynamics
12.1 Avian Influenza Vaccines Industry Trends
12.2 Avian Influenza Vaccines Market Drivers
12.3 Avian Influenza Vaccines Market Challenges
12.4 Avian Influenza Vaccines Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Avian Influenza Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Avian Influenza Vaccines Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 H5+H7 Avian Influenza Vaccines
1.2.3 H9 Avian Influenza Vaccines
1.3 Market by Application
1.3.1 Global Avian Influenza Vaccines Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Chicken
1.3.3 Duck & Goose
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Avian Influenza Vaccines Market Size Estimates and Forecasts
2.1.1 Global Avian Influenza Vaccines Revenue 2020-2031
2.1.2 Global Avian Influenza Vaccines Sales 2020-2031
2.2 Avian Influenza Vaccines Market Size by Region: 2024 Versus 2031
2.3 Avian Influenza Vaccines Sales by Region (2020-2031)
2.3.1 Global Avian Influenza Vaccines Sales by Region: 2020-2025
2.3.2 Global Avian Influenza Vaccines Sales Forecast by Region (2026-2031)
2.3.3 Global Avian Influenza Vaccines Sales Market Share by Region (2020-2031)
2.4 Avian Influenza Vaccines Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Avian Influenza Vaccines Revenue by Region: 2020-2025
2.4.2 Global Avian Influenza Vaccines Revenue Forecast by Region (2026-2031)
2.4.3 Global Avian Influenza Vaccines Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Avian Influenza Vaccines Sales by Type (2020-2031)
3.1.1.1 Global Avian Influenza Vaccines Sales Volume by Type (2020-2031)
3.1.1.2 Global Avian Influenza Vaccines Sales Market Share by Type (2020-2031)
3.1.2 Global Avian Influenza Vaccines Revenue by Type (2020-2031)
3.1.2.1 Global Avian Influenza Vaccines Revenue by Type (2020-2031)
3.1.2.2 Global Avian Influenza Vaccines Revenue Market Share by Type (2020-2031)
3.1.3 Avian Influenza Vaccines Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Avian Influenza Vaccines Sales by Application (2020-2031)
3.2.1.1 Global Avian Influenza Vaccines Sales Volume by Application (2020-2031)
3.2.1.2 Global Avian Influenza Vaccines Sales Market Share by Application (2020-2031)
3.2.2 Global Avian Influenza Vaccines Revenue by Application (2020-2031)
3.2.2.1 Global Avian Influenza Vaccines Revenue by Application (2020-2031)
3.2.2.2 Global Avian Influenza Vaccines Revenue Market Share by Application (2020-2031)
3.2.3 Avian Influenza Vaccines Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 H5+H7 Avian Influenza Vaccines of Avian Influenza Vaccines Revenue Market Share by Application
3.3.2 H9 Avian Influenza Vaccines of Avian Influenza Vaccines Revenue Market Share by Application
4 Global Avian Influenza Vaccines by Manufacturers
4.1 Global Top Avian Influenza Vaccines Manufacturers by Sales (2020-2025)
4.1.1 Global Avian Influenza Vaccines Sales by Manufacturer (2020-2025)
4.1.2 Global Avian Influenza Vaccines Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Avian Influenza Vaccines Manufacturers by Revenue (2020-2025)
4.2.1 Global Avian Influenza Vaccines Revenue by Manufacturer (2020-2025)
4.2.2 Global Avian Influenza Vaccines Revenue Share by Manufacturer (2020-2025)
4.3 Global Avian Influenza Vaccines Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Avian Influenza Vaccines Manufacturers Covered: Ranking by Revenue
4.4.2 Global Avian Influenza Vaccines Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Avian Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Avian Influenza Vaccines Manufacturing Base Distribution, Product Type
4.5.1 Avian Influenza Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Avian Influenza Vaccines Market
4.5.3 Manufacturers Avian Influenza Vaccines Product Type and Application
4.5.4 H5+H7 Avian Influenza Vaccines Market Sales of Avian Influenza Vaccines by Manufacturer
4.5.5 H9 Avian Influenza Vaccines Market Sales of Avian Influenza Vaccines by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Boehringer Ingelheim
5.1.1 Boehringer Ingelheim Company Information
5.1.2 Boehringer Ingelheim Description, Business Overview
5.1.3 Boehringer Ingelheim Avian Influenza Vaccines Products Offered
5.1.4 Boehringer Ingelheim Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Boehringer Ingelheim Avian Influenza Vaccines Sales by Product in 2024
5.1.6 Boehringer Ingelheim Avian Influenza Vaccines Sales by Application in 2024
5.1.7 Boehringer Ingelheim Avian Influenza Vaccines Sales by Geographic Area in 2024
5.1.8 Boehringer Ingelheim Recent Developments
5.2 CAHIC
5.2.1 CAHIC Company Information
5.2.2 CAHIC Description, Business Overview
5.2.3 CAHIC Avian Influenza Vaccines Products Offered
5.2.4 CAHIC Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.2.5 CAHIC Avian Influenza Vaccines Sales by Product in 2024
5.2.6 CAHIC Avian Influenza Vaccines Sales by Application in 2024
5.2.7 CAHIC Avian Influenza Vaccines Sales by Geographic Area in 2024
5.2.8 CAHIC Recent Developments
5.3 DHN
5.3.1 DHN Company Information
5.3.2 DHN Description, Business Overview
5.3.3 DHN Avian Influenza Vaccines Products Offered
5.3.4 DHN Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.3.5 DHN Avian Influenza Vaccines Sales by Product in 2024
5.3.6 DHN Avian Influenza Vaccines Sales by Application in 2024
5.3.7 DHN Avian Influenza Vaccines Sales by Geographic Area in 2024
5.3.8 DHN Recent Developments
5.4 HVRI
5.4.1 HVRI Company Information
5.4.2 HVRI Description, Business Overview
5.4.3 HVRI Avian Influenza Vaccines Products Offered
5.4.4 HVRI Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.4.5 HVRI Avian Influenza Vaccines Sales by Product in 2024
5.4.6 HVRI Avian Influenza Vaccines Sales by Application in 2024
5.4.7 HVRI Avian Influenza Vaccines Sales by Geographic Area in 2024
5.4.8 HVRI Recent Developments
5.5 CEVA
5.5.1 CEVA Company Information
5.5.2 CEVA Description, Business Overview
5.5.3 CEVA Avian Influenza Vaccines Products Offered
5.5.4 CEVA Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.5.5 CEVA Avian Influenza Vaccines Sales by Product in 2024
5.5.6 CEVA Avian Influenza Vaccines Sales by Application in 2024
5.5.7 CEVA Avian Influenza Vaccines Sales by Geographic Area in 2024
5.5.8 CEVA Recent Developments
5.6 Elanco Animal Health
5.6.1 Elanco Animal Health Company Information
5.6.2 Elanco Animal Health Description, Business Overview
5.6.3 Elanco Animal Health Avian Influenza Vaccines Products Offered
5.6.4 Elanco Animal Health Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Elanco Animal Health Avian Influenza Vaccines Sales by Product in 2024
5.6.6 Elanco Animal Health Avian Influenza Vaccines Sales by Application in 2024
5.6.7 Elanco Animal Health Avian Influenza Vaccines Sales by Geographic Area in 2024
5.6.8 Elanco Animal Health Recent Developments
5.7 Zoetis
5.7.1 Zoetis Company Information
5.7.2 Zoetis Description, Business Overview
5.7.3 Zoetis Avian Influenza Vaccines Products Offered
5.7.4 Zoetis Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Zoetis Avian Influenza Vaccines Sales by Product in 2024
5.7.6 Zoetis Avian Influenza Vaccines Sales by Application in 2024
5.7.7 Zoetis Avian Influenza Vaccines Sales by Geographic Area in 2024
5.7.8 Zoetis Recent Developments
5.8 FATRO
5.8.1 FATRO Company Information
5.8.2 FATRO Description, Business Overview
5.8.3 FATRO Avian Influenza Vaccines Products Offered
5.8.4 FATRO Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.8.5 FATRO Avian Influenza Vaccines Sales by Product in 2024
5.8.6 FATRO Avian Influenza Vaccines Sales by Application in 2024
5.8.7 FATRO Avian Influenza Vaccines Sales by Geographic Area in 2024
5.8.8 FATRO Recent Developments
5.9 Kyoto Biken
5.9.1 Kyoto Biken Company Information
5.9.2 Kyoto Biken Description, Business Overview
5.9.3 Kyoto Biken Avian Influenza Vaccines Products Offered
5.9.4 Kyoto Biken Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Kyoto Biken Avian Influenza Vaccines Sales by Product in 2024
5.9.6 Kyoto Biken Avian Influenza Vaccines Sales by Application in 2024
5.9.7 Kyoto Biken Avian Influenza Vaccines Sales by Geographic Area in 2024
5.9.8 Kyoto Biken Recent Developments
5.10 CAVAC
5.10.1 CAVAC Company Information
5.10.2 CAVAC Description, Business Overview
5.10.3 CAVAC Avian Influenza Vaccines Products Offered
5.10.4 CAVAC Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.10.5 CAVAC Avian Influenza Vaccines Sales by Product in 2024
5.10.6 CAVAC Avian Influenza Vaccines Sales by Application in 2024
5.10.7 CAVAC Avian Influenza Vaccines Sales by Geographic Area in 2024
5.10.8 CAVAC Recent Developments
5.11 Ringpu Biology
5.11.1 Ringpu Biology Company Information
5.11.2 Ringpu Biology Description, Business Overview
5.11.3 Ringpu Biology Avian Influenza Vaccines Products Offered
5.11.4 Ringpu Biology Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Ringpu Biology Avian Influenza Vaccines Sales by Product in 2024
5.11.6 Ringpu Biology Avian Influenza Vaccines Sales by Application in 2024
5.11.7 Ringpu Biology Avian Influenza Vaccines Sales by Geographic Area in 2024
5.11.8 Ringpu Biology Recent Developments
5.12 Vaksindo
5.12.1 Vaksindo Company Information
5.12.2 Vaksindo Description, Business Overview
5.12.3 Vaksindo Avian Influenza Vaccines Products Offered
5.12.4 Vaksindo Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Vaksindo Avian Influenza Vaccines Sales by Product in 2024
5.12.6 Vaksindo Avian Influenza Vaccines Sales by Application in 2024
5.12.7 Vaksindo Avian Influenza Vaccines Sales by Geographic Area in 2024
5.12.8 Vaksindo Recent Developments
5.13 Sindh Poultry Vaccine Centre
5.13.1 Sindh Poultry Vaccine Centre Company Information
5.13.2 Sindh Poultry Vaccine Centre Description, Business Overview
5.13.3 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Products Offered
5.13.4 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.13.5 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales by Product in 2024
5.13.6 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales by Application in 2024
5.13.7 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales by Geographic Area in 2024
5.13.8 Sindh Poultry Vaccine Centre Recent Developments
5.14 Merck Animal Health
5.14.1 Merck Animal Health Company Information
5.14.2 Merck Animal Health Description, Business Overview
5.14.3 Merck Animal Health Avian Influenza Vaccines Products Offered
5.14.4 Merck Animal Health Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.14.5 Merck Animal Health Avian Influenza Vaccines Sales by Product in 2024
5.14.6 Merck Animal Health Avian Influenza Vaccines Sales by Application in 2024
5.14.7 Merck Animal Health Avian Influenza Vaccines Sales by Geographic Area in 2024
5.14.8 Merck Animal Health Recent Developments
5.15 PT Medion Farma Jaya
5.15.1 PT Medion Farma Jaya Company Information
5.15.2 PT Medion Farma Jaya Description, Business Overview
5.15.3 PT Medion Farma Jaya Avian Influenza Vaccines Products Offered
5.15.4 PT Medion Farma Jaya Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.15.5 PT Medion Farma Jaya Avian Influenza Vaccines Sales by Product in 2024
5.15.6 PT Medion Farma Jaya Avian Influenza Vaccines Sales by Application in 2024
5.15.7 PT Medion Farma Jaya Avian Influenza Vaccines Sales by Geographic Area in 2024
5.15.8 PT Medion Farma Jaya Recent Developments
5.16 Avimex Animal Health
5.16.1 Avimex Animal Health Company Information
5.16.2 Avimex Animal Health Description, Business Overview
5.16.3 Avimex Animal Health Avian Influenza Vaccines Products Offered
5.16.4 Avimex Animal Health Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.16.5 Avimex Animal Health Avian Influenza Vaccines Sales by Product in 2024
5.16.6 Avimex Animal Health Avian Influenza Vaccines Sales by Application in 2024
5.16.7 Avimex Animal Health Avian Influenza Vaccines Sales by Geographic Area in 2024
5.16.8 Avimex Animal Health Recent Developments
5.17 JOVAC
5.17.1 JOVAC Company Information
5.17.2 JOVAC Description, Business Overview
5.17.3 JOVAC Avian Influenza Vaccines Products Offered
5.17.4 JOVAC Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.17.5 JOVAC Avian Influenza Vaccines Sales by Product in 2024
5.17.6 JOVAC Avian Influenza Vaccines Sales by Application in 2024
5.17.7 JOVAC Avian Influenza Vaccines Sales by Geographic Area in 2024
5.17.8 JOVAC Recent Developments
5.18 Bio-Labs
5.18.1 Bio-Labs Company Information
5.18.2 Bio-Labs Description, Business Overview
5.18.3 Bio-Labs Avian Influenza Vaccines Products Offered
5.18.4 Bio-Labs Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.18.5 Bio-Labs Avian Influenza Vaccines Sales by Product in 2024
5.18.6 Bio-Labs Avian Influenza Vaccines Sales by Application in 2024
5.18.7 Bio-Labs Avian Influenza Vaccines Sales by Geographic Area in 2024
5.18.8 Bio-Labs Recent Developments
5.19 Pusvetma
5.19.1 Pusvetma Company Information
5.19.2 Pusvetma Description, Business Overview
5.19.3 Pusvetma Avian Influenza Vaccines Products Offered
5.19.4 Pusvetma Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.19.5 Pusvetma Avian Influenza Vaccines Sales by Product in 2024
5.19.6 Pusvetma Avian Influenza Vaccines Sales by Application in 2024
5.19.7 Pusvetma Avian Influenza Vaccines Sales by Geographic Area in 2024
5.19.8 Pusvetma Recent Developments
5.20 IPB-Shigeta
5.20.1 IPB-Shigeta Company Information
5.20.2 IPB-Shigeta Description, Business Overview
5.20.3 IPB-Shigeta Avian Influenza Vaccines Products Offered
5.20.4 IPB-Shigeta Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.20.5 IPB-Shigeta Avian Influenza Vaccines Sales by Product in 2024
5.20.6 IPB-Shigeta Avian Influenza Vaccines Sales by Application in 2024
5.20.7 IPB-Shigeta Avian Influenza Vaccines Sales by Geographic Area in 2024
5.20.8 IPB-Shigeta Recent Developments
5.21 Medion Farma Jaya
5.21.1 Medion Farma Jaya Company Information
5.21.2 Medion Farma Jaya Description, Business Overview
5.21.3 Medion Farma Jaya Avian Influenza Vaccines Products Offered
5.21.4 Medion Farma Jaya Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.21.5 Medion Farma Jaya Avian Influenza Vaccines Sales by Product in 2024
5.21.6 Medion Farma Jaya Avian Influenza Vaccines Sales by Application in 2024
5.21.7 Medion Farma Jaya Avian Influenza Vaccines Sales by Geographic Area in 2024
5.21.8 Medion Farma Jaya Recent Developments
5.22 Caprifamarindo
5.22.1 Caprifamarindo Company Information
5.22.2 Caprifamarindo Description, Business Overview
5.22.3 Caprifamarindo Avian Influenza Vaccines Products Offered
5.22.4 Caprifamarindo Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.22.5 Caprifamarindo Avian Influenza Vaccines Sales by Product in 2024
5.22.6 Caprifamarindo Avian Influenza Vaccines Sales by Application in 2024
5.22.7 Caprifamarindo Avian Influenza Vaccines Sales by Geographic Area in 2024
5.22.8 Caprifamarindo Recent Developments
6 North America
6.1 North America Avian Influenza Vaccines Market Size YoY Growth 2020-2031
6.2 North America Avian Influenza Vaccines Market Facts & Figures by Country
6.2.1 North America Avian Influenza Vaccines Sales by Country (2020-2031)
6.2.2 North America Avian Influenza Vaccines Revenue by Country (2020-2031)
6.3 North America Avian Influenza Vaccines Sales by Type (2020-2025)
6.4 North America Avian Influenza Vaccines Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Avian Influenza Vaccines Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Avian Influenza Vaccines Market Facts & Figures by Region
7.2.1 Asia-Pacific Avian Influenza Vaccines Sales by Region (2020-2031)
7.2.2 Asia-Pacific Avian Influenza Vaccines Revenue by Region (2020-2031)
7.3 Asia-Pacific Avian Influenza Vaccines Sales by Type (2020-2025)
7.4 Asia-Pacific Avian Influenza Vaccines Sales by Application (2020-2025)
8 Europe
8.1 Europe Avian Influenza Vaccines Market Size YoY Growth 2020-2031
8.2 Europe Avian Influenza Vaccines Market Facts & Figures by Country
8.2.1 Europe Avian Influenza Vaccines Sales by Country (2020-2031)
8.2.2 Europe Avian Influenza Vaccines Revenue by Country (2020-2031)
8.3 Europe Avian Influenza Vaccines Sales by Type (2020-2025)
8.4 Europe Avian Influenza Vaccines Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Avian Influenza Vaccines Market Size YoY Growth 2020-2031
9.2 Latin America Avian Influenza Vaccines Market Facts & Figures by Country
9.2.1 Latin America Avian Influenza Vaccines Sales by Country (2020-2031)
9.2.2 Latin America Avian Influenza Vaccines Revenue by Country (2020-2031)
9.3 Latin America Avian Influenza Vaccines Sales by Type (2020-2025)
9.4 Latin America Avian Influenza Vaccines Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Avian Influenza Vaccines Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Avian Influenza Vaccines Market Facts & Figures by Country
10.2.1 Middle East and Africa Avian Influenza Vaccines Sales by Country (2020-2031)
10.2.2 Middle East and Africa Avian Influenza Vaccines Revenue by Country (2020-2031)
10.3 Middle East and Africa Avian Influenza Vaccines Sales by Type (2020-2025)
10.4 Middle East and Africa Avian Influenza Vaccines Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Avian Influenza Vaccines Supply Chain Analysis
11.2 Avian Influenza Vaccines Key Raw Materials and Upstream Suppliers
11.3 Avian Influenza Vaccines Clients Analysis
11.4 Avian Influenza Vaccines Sales Channel and Sales Model Analysis
11.4.1 Avian Influenza Vaccines Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Avian Influenza Vaccines Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Avian Influenza Vaccines Distributors
12 Avian Influenza Vaccines Market Dynamics
12.1 Avian Influenza Vaccines Industry Trends
12.2 Avian Influenza Vaccines Market Drivers
12.3 Avian Influenza Vaccines Market Challenges
12.4 Avian Influenza Vaccines Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Avian Influenza Vaccines Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Avian Influenza Vaccines Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Avian Influenza Vaccines Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Avian Influenza Vaccines Sales by Region (2020-2025) & (M Doses)
Table 5. Global Avian Influenza Vaccines Sales Forecast by Region (2026-2031) & (M Doses)
Table 6. Global Avian Influenza Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Avian Influenza Vaccines Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Avian Influenza Vaccines Sales Volume by Type (2020-2025) & (M Doses)
Table 9. Global Avian Influenza Vaccines Sales Volume by Type (2026-2031) & (M Doses)
Table 10. Global Avian Influenza Vaccines Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Avian Influenza Vaccines Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Avian Influenza Vaccines Sales Volume by Application (2020-2025) & (M Doses)
Table 13. Global Avian Influenza Vaccines Sales Volume by Application (2026-2031) & (M Doses)
Table 14. Global Avian Influenza Vaccines Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Avian Influenza Vaccines Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Avian Influenza Vaccines Sales by Manufacturer (2020-2025) & (M Doses)
Table 17. Global Avian Influenza Vaccines Sales Share by Manufacturer (2020-2025)
Table 18. Avian Influenza Vaccines Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Avian Influenza Vaccines Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Avian Influenza Vaccines Price (2020-2025) & (USD/K Doses)
Table 21. Ranking of Global Top Avian Influenza Vaccines Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Avian Influenza Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Avian Influenza Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Avian Influenza Vaccines as of 2024)
Table 24. Avian Influenza Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Avian Influenza Vaccines Market
Table 26. Manufacturers Avian Influenza Vaccines Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Boehringer Ingelheim Company Information
Table 29. Boehringer Ingelheim Description and Business Overview
Table 30. Boehringer Ingelheim Avian Influenza Vaccines Product
Table 31. Boehringer Ingelheim Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 32. Boehringer Ingelheim Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 33. Boehringer Ingelheim Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 34. Boehringer Ingelheim Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 35. Boehringer Ingelheim Recent Developments
Table 36. CAHIC Company Information
Table 37. CAHIC Description and Business Overview
Table 38. CAHIC Avian Influenza Vaccines Product
Table 39. CAHIC Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 40. CAHIC Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 41. CAHIC Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 42. CAHIC Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 43. CAHIC Recent Developments
Table 44. DHN Company Information
Table 45. DHN Description and Business Overview
Table 46. DHN Avian Influenza Vaccines Product
Table 47. DHN Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 48. DHN Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 49. DHN Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 50. DHN Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 51. DHN Recent Developments
Table 52. HVRI Company Information
Table 53. HVRI Description and Business Overview
Table 54. HVRI Avian Influenza Vaccines Product
Table 55. HVRI Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 56. HVRI Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 57. HVRI Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 58. HVRI Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 59. HVRI Recent Developments
Table 60. CEVA Company Information
Table 61. CEVA Description and Business Overview
Table 62. CEVA Avian Influenza Vaccines Product
Table 63. CEVA Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 64. CEVA Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 65. CEVA Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 66. CEVA Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 67. CEVA Recent Developments
Table 68. Elanco Animal Health Company Information
Table 69. Elanco Animal Health Description and Business Overview
Table 70. Elanco Animal Health Avian Influenza Vaccines Product
Table 71. Elanco Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 72. Elanco Animal Health Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 73. Elanco Animal Health Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 74. Elanco Animal Health Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 75. Elanco Animal Health Recent Developments
Table 76. Zoetis Company Information
Table 77. Zoetis Description and Business Overview
Table 78. Zoetis Avian Influenza Vaccines Product
Table 79. Zoetis Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 80. Zoetis Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 81. Zoetis Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 82. Zoetis Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 83. Zoetis Recent Developments
Table 84. FATRO Company Information
Table 85. FATRO Description and Business Overview
Table 86. FATRO Avian Influenza Vaccines Product
Table 87. FATRO Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 88. FATRO Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 89. FATRO Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 90. FATRO Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 91. FATRO Recent Developments
Table 92. Kyoto Biken Company Information
Table 93. Kyoto Biken Description and Business Overview
Table 94. Kyoto Biken Avian Influenza Vaccines Product
Table 95. Kyoto Biken Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 96. Kyoto Biken Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 97. Kyoto Biken Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 98. Kyoto Biken Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 99. Kyoto Biken Recent Developments
Table 100. CAVAC Company Information
Table 101. CAVAC Description and Business Overview
Table 102. CAVAC Avian Influenza Vaccines Product
Table 103. CAVAC Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 104. CAVAC Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 105. CAVAC Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 106. CAVAC Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 107. CAVAC Recent Developments
Table 108. Ringpu Biology Company Information
Table 109. Ringpu Biology Description and Business Overview
Table 110. Ringpu Biology Avian Influenza Vaccines Product
Table 111. Ringpu Biology Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 112. Ringpu Biology Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 113. Ringpu Biology Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 114. Ringpu Biology Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 115. Ringpu Biology Recent Developments
Table 116. Vaksindo Company Information
Table 117. Vaksindo Description and Business Overview
Table 118. Vaksindo Avian Influenza Vaccines Product
Table 119. Vaksindo Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 120. Vaksindo Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 121. Vaksindo Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 122. Vaksindo Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 123. Vaksindo Recent Developments
Table 124. Sindh Poultry Vaccine Centre Company Information
Table 125. Sindh Poultry Vaccine Centre Description and Business Overview
Table 126. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product
Table 127. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 128. Sindh Poultry Vaccine Centre Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 129. Sindh Poultry Vaccine Centre Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 130. Sindh Poultry Vaccine Centre Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 131. Sindh Poultry Vaccine Centre Recent Developments
Table 132. Merck Animal Health Company Information
Table 133. Merck Animal Health Description and Business Overview
Table 134. Merck Animal Health Avian Influenza Vaccines Product
Table 135. Merck Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 136. Merck Animal Health Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 137. Merck Animal Health Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 138. Merck Animal Health Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 139. Merck Animal Health Recent Developments
Table 140. PT Medion Farma Jaya Company Information
Table 141. PT Medion Farma Jaya Description and Business Overview
Table 142. PT Medion Farma Jaya Avian Influenza Vaccines Product
Table 143. PT Medion Farma Jaya Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 144. PT Medion Farma Jaya Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 145. PT Medion Farma Jaya Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 146. PT Medion Farma Jaya Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 147. PT Medion Farma Jaya Recent Developments
Table 148. Avimex Animal Health Company Information
Table 149. Avimex Animal Health Description and Business Overview
Table 150. Avimex Animal Health Avian Influenza Vaccines Product
Table 151. Avimex Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 152. Avimex Animal Health Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 153. Avimex Animal Health Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 154. Avimex Animal Health Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 155. Avimex Animal Health Recent Developments
Table 156. JOVAC Company Information
Table 157. JOVAC Description and Business Overview
Table 158. JOVAC Avian Influenza Vaccines Product
Table 159. JOVAC Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 160. JOVAC Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 161. JOVAC Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 162. JOVAC Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 163. JOVAC Recent Developments
Table 164. Bio-Labs Company Information
Table 165. Bio-Labs Description and Business Overview
Table 166. Bio-Labs Avian Influenza Vaccines Product
Table 167. Bio-Labs Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 168. Bio-Labs Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 169. Bio-Labs Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 170. Bio-Labs Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 171. Bio-Labs Recent Developments
Table 172. Pusvetma Company Information
Table 173. Pusvetma Description and Business Overview
Table 174. Pusvetma Avian Influenza Vaccines Product
Table 175. Pusvetma Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 176. Pusvetma Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 177. Pusvetma Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 178. Pusvetma Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 179. Pusvetma Recent Developments
Table 180. IPB-Shigeta Company Information
Table 181. IPB-Shigeta Description and Business Overview
Table 182. IPB-Shigeta Avian Influenza Vaccines Product
Table 183. IPB-Shigeta Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 184. IPB-Shigeta Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 185. IPB-Shigeta Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 186. IPB-Shigeta Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 187. IPB-Shigeta Recent Developments
Table 188. Medion Farma Jaya Company Information
Table 189. Medion Farma Jaya Description and Business Overview
Table 190. Medion Farma Jaya Avian Influenza Vaccines Product
Table 191. Medion Farma Jaya Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 192. Medion Farma Jaya Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 193. Medion Farma Jaya Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 194. Medion Farma Jaya Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 195. Medion Farma Jaya Recent Developments
Table 196. Caprifamarindo Company Information
Table 197. Caprifamarindo Description and Business Overview
Table 198. Caprifamarindo Avian Influenza Vaccines Product
Table 199. Caprifamarindo Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 200. Caprifamarindo Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 201. Caprifamarindo Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 202. Caprifamarindo Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 203. Caprifamarindo Recent Developments
Table 204. North America Avian Influenza Vaccines Sales by Country (2020-2025) & (M Doses)
Table 205. North America Avian Influenza Vaccines Sales by Country (2026-2031) & (M Doses)
Table 206. North America Avian Influenza Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 207. North America Avian Influenza Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 208. North America Avian Influenza Vaccines Sales by Type (2020-2025) & (M Doses)
Table 209. North America Avian Influenza Vaccines Sales by Application (2020-2025) & (M Doses)
Table 210. Asia-Pacific Avian Influenza Vaccines Sales by Region (2020-2025) & (M Doses)
Table 211. Asia-Pacific Avian Influenza Vaccines Sales by Region (2026-2031) & (M Doses)
Table 212. Asia-Pacific Avian Influenza Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 213. Asia-Pacific Avian Influenza Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 214. Asia-Pacific Avian Influenza Vaccines Sales by Type (2020-2025) & (M Doses)
Table 215. Asia-Pacific Avian Influenza Vaccines Sales by Application (2020-2025) & (M Doses)
Table 216. Europe Avian Influenza Vaccines Sales by Country (2020-2025) & (M Doses)
Table 217. Europe Avian Influenza Vaccines Sales by Country (2026-2031) & (M Doses)
Table 218. Europe Avian Influenza Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 219. Europe Avian Influenza Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 220. Europe Avian Influenza Vaccines Sales by Type (2020-2025) & (M Doses)
Table 221. Europe Avian Influenza Vaccines Sales by Application (2020-2025) & (M Doses)
Table 222. Latin America Avian Influenza Vaccines Sales by Country (2020-2025) & (M Doses)
Table 223. Latin America Avian Influenza Vaccines Sales by Country (2026-2031) & (M Doses)
Table 224. Latin America Avian Influenza Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 225. Latin America Avian Influenza Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 226. Latin America Avian Influenza Vaccines Sales by Type (2020-2025) & (M Doses)
Table 227. Latin America Avian Influenza Vaccines Sales by Application (2020-2025) & (M Doses)
Table 228. Middle East and Africa Avian Influenza Vaccines Sales by Country (2020-2025) & (M Doses)
Table 229. Middle East and Africa Avian Influenza Vaccines Sales by Country (2026-2031) & (M Doses)
Table 230. Middle East and Africa Avian Influenza Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 231. Middle East and Africa Avian Influenza Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 232. Middle East and Africa Avian Influenza Vaccines Sales by Type (2020-2025) & (M Doses)
Table 233. Middle East and Africa Avian Influenza Vaccines Sales by Application (2020-2025) & (M Doses)
Table 234. Avian Influenza Vaccines Key Raw Materials, Industry Status and Trend
Table 235. Avian Influenza Vaccines Key Raw Materials and Upstream Suppliers
Table 236. Avian Influenza Vaccines Clients Status and Trend
Table 237. Avian Influenza Vaccines Typical Clients
Table 238. Avian Influenza Vaccines Distributors
Table 239. Avian Influenza Vaccines Market Trends
Table 240. Avian Influenza Vaccines Market Drivers
Table 241. Avian Influenza Vaccines Market Challenges
Table 242. Avian Influenza Vaccines Market Restraints
Table 243. Research Programs/Design for This Report
Table 244. Key Data Information from Secondary Sources
Table 245. Key Data Information from Primary Sources
Table 246. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Avian Influenza Vaccines Product Picture
Figure 2. Global Avian Influenza Vaccines Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Avian Influenza Vaccines Sales Market Share by Type in 2024 & 2031
Figure 4. H5+H7 Avian Influenza Vaccines Product Picture
Figure 5. H9 Avian Influenza Vaccines Product Picture
Figure 6. Global Avian Influenza Vaccines Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Avian Influenza Vaccines Sales Market Share by Application in 2024 & 2031
Figure 8. Chicken
Figure 9. Duck & Goose
Figure 10. Other
Figure 11. Avian Influenza Vaccines Report Years Considered
Figure 12. Global Avian Influenza Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Avian Influenza Vaccines Market Size 2020-2031 (US$ Million)
Figure 14. Global Avian Influenza Vaccines Sales 2020-2031 (M Doses)
Figure 15. Global Avian Influenza Vaccines Sales Market Share Forecast by Region (2020-2031)
Figure 16. Global Avian Influenza Vaccines Revenue Market Share by Region (2020-2031)
Figure 17. Global Avian Influenza Vaccines Sales Market Share Forecast by Type (2020-2031)
Figure 18. Global Avian Influenza Vaccines Revenue Market Share Forecast by Type (2020-2031)
Figure 19. Avian Influenza Vaccines Average Selling Price (ASP) by Type (2020-2025) & (USD/K Doses)
Figure 20. Global Avian Influenza Vaccines Sales Market Share Forecast by Application (2020-2031)
Figure 21. Global Avian Influenza Vaccines Revenue Market Share Forecast by Application (2020-2031)
Figure 22. Avian Influenza Vaccines Average Selling Price (ASP) by Application (2020-2025) & (USD/K Doses)
Figure 23. H5+H7 Avian Influenza Vaccines of Avian Influenza Vaccines Revenue Market Share by Application, 2024 VS 2031
Figure 24. H9 Avian Influenza Vaccines of Avian Influenza Vaccines Revenue Market Share by Application, 2024 VS 2031
Figure 25. Global Avian Influenza Vaccines Sales Share by Manufacturer in 2024
Figure 26. Avian Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 27. H5+H7 Avian Influenza Vaccines Market Sales Proportion by Manufacturer in 2024
Figure 28. H9 Avian Influenza Vaccines Market Sales Proportion by Manufacturer in 2024
Figure 29. North America Avian Influenza Vaccines Revenue 2020-2031 (US$ Million)
Figure 30. North America Avian Influenza Vaccines Sales Market Share by Type (2020-2025)
Figure 31. North America Avian Influenza Vaccines Sales Market Share by Application (2020-2025)
Figure 32. Asia-Pacific Avian Influenza Vaccines Revenue 2020-2031 (US$ Million)
Figure 33. Asia-Pacific Avian Influenza Vaccines Sales Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Avian Influenza Vaccines Revenue Market Share by Region (2020-2031)
Figure 35. Asia-Pacific Avian Influenza Vaccines Sales Market Share by Type (2020-2025)
Figure 36. Asia-Pacific Avian Influenza Vaccines Sales Market Share by Application (2020-2025)
Figure 37. Europe Avian Influenza Vaccines Revenue Growth Rate 2020-2031 (US$ Million)
Figure 38. Europe Avian Influenza Vaccines Sales Market Share by Country (2020-2031)
Figure 39. Europe Avian Influenza Vaccines Revenue Market Share by Country (2020-2031)
Figure 40. Europe Avian Influenza Vaccines Sales Market Share by Type (2020-2025)
Figure 41. Europe Avian Influenza Vaccines Sales Market Share by Application (2020-2025)
Figure 42. Latin America Avian Influenza Vaccines Revenue Growth Rate 2020-2031 (US$ Million)
Figure 43. Latin America Avian Influenza Vaccines Sales Market Share by Country (2020-2031)
Figure 44. Latin America Avian Influenza Vaccines Revenue Market Share by Country (2020-2025)
Figure 45. Latin America Avian Influenza Vaccines Sales Market Share by Type (2020-2025)
Figure 46. Latin America Avian Influenza Vaccines Sales Market Share by Application (2020-2025)
Figure 47. Middle East and Africa Avian Influenza Vaccines Revenue Growth Rate 2020-2031 (US$ Million)
Figure 48. Middle East and Africa Avian Influenza Vaccines Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Avian Influenza Vaccines Revenue Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Avian Influenza Vaccines Sales Market Share by Type (2020-2025)
Figure 51. Middle East and Africa Avian Influenza Vaccines Sales Market Share by Application (2020-2025)
Figure 52. Avian Influenza Vaccines Supply Chain (Upstream and Downstream Market)
Figure 53. Global Production Market Share of Avian Influenza Vaccines Raw Materials by Region in 2024
Figure 54. Avian Influenza Vaccines Distribution Channels
Figure 55. Global Avian Influenza Vaccines Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 56. Global Avian Influenza Vaccines Percentage 2020-2031: Online Sales VS Offline Sales
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Table 1. Global Avian Influenza Vaccines Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Avian Influenza Vaccines Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Avian Influenza Vaccines Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Avian Influenza Vaccines Sales by Region (2020-2025) & (M Doses)
Table 5. Global Avian Influenza Vaccines Sales Forecast by Region (2026-2031) & (M Doses)
Table 6. Global Avian Influenza Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Avian Influenza Vaccines Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Avian Influenza Vaccines Sales Volume by Type (2020-2025) & (M Doses)
Table 9. Global Avian Influenza Vaccines Sales Volume by Type (2026-2031) & (M Doses)
Table 10. Global Avian Influenza Vaccines Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Avian Influenza Vaccines Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Avian Influenza Vaccines Sales Volume by Application (2020-2025) & (M Doses)
Table 13. Global Avian Influenza Vaccines Sales Volume by Application (2026-2031) & (M Doses)
Table 14. Global Avian Influenza Vaccines Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Avian Influenza Vaccines Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Avian Influenza Vaccines Sales by Manufacturer (2020-2025) & (M Doses)
Table 17. Global Avian Influenza Vaccines Sales Share by Manufacturer (2020-2025)
Table 18. Avian Influenza Vaccines Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Avian Influenza Vaccines Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Avian Influenza Vaccines Price (2020-2025) & (USD/K Doses)
Table 21. Ranking of Global Top Avian Influenza Vaccines Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Avian Influenza Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Avian Influenza Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Avian Influenza Vaccines as of 2024)
Table 24. Avian Influenza Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Avian Influenza Vaccines Market
Table 26. Manufacturers Avian Influenza Vaccines Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Boehringer Ingelheim Company Information
Table 29. Boehringer Ingelheim Description and Business Overview
Table 30. Boehringer Ingelheim Avian Influenza Vaccines Product
Table 31. Boehringer Ingelheim Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 32. Boehringer Ingelheim Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 33. Boehringer Ingelheim Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 34. Boehringer Ingelheim Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 35. Boehringer Ingelheim Recent Developments
Table 36. CAHIC Company Information
Table 37. CAHIC Description and Business Overview
Table 38. CAHIC Avian Influenza Vaccines Product
Table 39. CAHIC Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 40. CAHIC Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 41. CAHIC Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 42. CAHIC Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 43. CAHIC Recent Developments
Table 44. DHN Company Information
Table 45. DHN Description and Business Overview
Table 46. DHN Avian Influenza Vaccines Product
Table 47. DHN Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 48. DHN Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 49. DHN Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 50. DHN Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 51. DHN Recent Developments
Table 52. HVRI Company Information
Table 53. HVRI Description and Business Overview
Table 54. HVRI Avian Influenza Vaccines Product
Table 55. HVRI Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 56. HVRI Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 57. HVRI Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 58. HVRI Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 59. HVRI Recent Developments
Table 60. CEVA Company Information
Table 61. CEVA Description and Business Overview
Table 62. CEVA Avian Influenza Vaccines Product
Table 63. CEVA Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 64. CEVA Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 65. CEVA Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 66. CEVA Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 67. CEVA Recent Developments
Table 68. Elanco Animal Health Company Information
Table 69. Elanco Animal Health Description and Business Overview
Table 70. Elanco Animal Health Avian Influenza Vaccines Product
Table 71. Elanco Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 72. Elanco Animal Health Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 73. Elanco Animal Health Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 74. Elanco Animal Health Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 75. Elanco Animal Health Recent Developments
Table 76. Zoetis Company Information
Table 77. Zoetis Description and Business Overview
Table 78. Zoetis Avian Influenza Vaccines Product
Table 79. Zoetis Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 80. Zoetis Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 81. Zoetis Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 82. Zoetis Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 83. Zoetis Recent Developments
Table 84. FATRO Company Information
Table 85. FATRO Description and Business Overview
Table 86. FATRO Avian Influenza Vaccines Product
Table 87. FATRO Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 88. FATRO Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 89. FATRO Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 90. FATRO Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 91. FATRO Recent Developments
Table 92. Kyoto Biken Company Information
Table 93. Kyoto Biken Description and Business Overview
Table 94. Kyoto Biken Avian Influenza Vaccines Product
Table 95. Kyoto Biken Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 96. Kyoto Biken Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 97. Kyoto Biken Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 98. Kyoto Biken Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 99. Kyoto Biken Recent Developments
Table 100. CAVAC Company Information
Table 101. CAVAC Description and Business Overview
Table 102. CAVAC Avian Influenza Vaccines Product
Table 103. CAVAC Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 104. CAVAC Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 105. CAVAC Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 106. CAVAC Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 107. CAVAC Recent Developments
Table 108. Ringpu Biology Company Information
Table 109. Ringpu Biology Description and Business Overview
Table 110. Ringpu Biology Avian Influenza Vaccines Product
Table 111. Ringpu Biology Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 112. Ringpu Biology Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 113. Ringpu Biology Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 114. Ringpu Biology Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 115. Ringpu Biology Recent Developments
Table 116. Vaksindo Company Information
Table 117. Vaksindo Description and Business Overview
Table 118. Vaksindo Avian Influenza Vaccines Product
Table 119. Vaksindo Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 120. Vaksindo Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 121. Vaksindo Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 122. Vaksindo Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 123. Vaksindo Recent Developments
Table 124. Sindh Poultry Vaccine Centre Company Information
Table 125. Sindh Poultry Vaccine Centre Description and Business Overview
Table 126. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product
Table 127. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 128. Sindh Poultry Vaccine Centre Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 129. Sindh Poultry Vaccine Centre Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 130. Sindh Poultry Vaccine Centre Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 131. Sindh Poultry Vaccine Centre Recent Developments
Table 132. Merck Animal Health Company Information
Table 133. Merck Animal Health Description and Business Overview
Table 134. Merck Animal Health Avian Influenza Vaccines Product
Table 135. Merck Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 136. Merck Animal Health Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 137. Merck Animal Health Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 138. Merck Animal Health Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 139. Merck Animal Health Recent Developments
Table 140. PT Medion Farma Jaya Company Information
Table 141. PT Medion Farma Jaya Description and Business Overview
Table 142. PT Medion Farma Jaya Avian Influenza Vaccines Product
Table 143. PT Medion Farma Jaya Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 144. PT Medion Farma Jaya Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 145. PT Medion Farma Jaya Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 146. PT Medion Farma Jaya Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 147. PT Medion Farma Jaya Recent Developments
Table 148. Avimex Animal Health Company Information
Table 149. Avimex Animal Health Description and Business Overview
Table 150. Avimex Animal Health Avian Influenza Vaccines Product
Table 151. Avimex Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 152. Avimex Animal Health Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 153. Avimex Animal Health Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 154. Avimex Animal Health Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 155. Avimex Animal Health Recent Developments
Table 156. JOVAC Company Information
Table 157. JOVAC Description and Business Overview
Table 158. JOVAC Avian Influenza Vaccines Product
Table 159. JOVAC Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 160. JOVAC Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 161. JOVAC Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 162. JOVAC Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 163. JOVAC Recent Developments
Table 164. Bio-Labs Company Information
Table 165. Bio-Labs Description and Business Overview
Table 166. Bio-Labs Avian Influenza Vaccines Product
Table 167. Bio-Labs Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 168. Bio-Labs Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 169. Bio-Labs Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 170. Bio-Labs Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 171. Bio-Labs Recent Developments
Table 172. Pusvetma Company Information
Table 173. Pusvetma Description and Business Overview
Table 174. Pusvetma Avian Influenza Vaccines Product
Table 175. Pusvetma Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 176. Pusvetma Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 177. Pusvetma Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 178. Pusvetma Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 179. Pusvetma Recent Developments
Table 180. IPB-Shigeta Company Information
Table 181. IPB-Shigeta Description and Business Overview
Table 182. IPB-Shigeta Avian Influenza Vaccines Product
Table 183. IPB-Shigeta Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 184. IPB-Shigeta Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 185. IPB-Shigeta Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 186. IPB-Shigeta Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 187. IPB-Shigeta Recent Developments
Table 188. Medion Farma Jaya Company Information
Table 189. Medion Farma Jaya Description and Business Overview
Table 190. Medion Farma Jaya Avian Influenza Vaccines Product
Table 191. Medion Farma Jaya Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 192. Medion Farma Jaya Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 193. Medion Farma Jaya Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 194. Medion Farma Jaya Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 195. Medion Farma Jaya Recent Developments
Table 196. Caprifamarindo Company Information
Table 197. Caprifamarindo Description and Business Overview
Table 198. Caprifamarindo Avian Influenza Vaccines Product
Table 199. Caprifamarindo Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 200. Caprifamarindo Sales Proportion of Avian Influenza Vaccines by Product in 2024
Table 201. Caprifamarindo Sales Proportion of Avian Influenza Vaccines by Application in 2024
Table 202. Caprifamarindo Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
Table 203. Caprifamarindo Recent Developments
Table 204. North America Avian Influenza Vaccines Sales by Country (2020-2025) & (M Doses)
Table 205. North America Avian Influenza Vaccines Sales by Country (2026-2031) & (M Doses)
Table 206. North America Avian Influenza Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 207. North America Avian Influenza Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 208. North America Avian Influenza Vaccines Sales by Type (2020-2025) & (M Doses)
Table 209. North America Avian Influenza Vaccines Sales by Application (2020-2025) & (M Doses)
Table 210. Asia-Pacific Avian Influenza Vaccines Sales by Region (2020-2025) & (M Doses)
Table 211. Asia-Pacific Avian Influenza Vaccines Sales by Region (2026-2031) & (M Doses)
Table 212. Asia-Pacific Avian Influenza Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 213. Asia-Pacific Avian Influenza Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 214. Asia-Pacific Avian Influenza Vaccines Sales by Type (2020-2025) & (M Doses)
Table 215. Asia-Pacific Avian Influenza Vaccines Sales by Application (2020-2025) & (M Doses)
Table 216. Europe Avian Influenza Vaccines Sales by Country (2020-2025) & (M Doses)
Table 217. Europe Avian Influenza Vaccines Sales by Country (2026-2031) & (M Doses)
Table 218. Europe Avian Influenza Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 219. Europe Avian Influenza Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 220. Europe Avian Influenza Vaccines Sales by Type (2020-2025) & (M Doses)
Table 221. Europe Avian Influenza Vaccines Sales by Application (2020-2025) & (M Doses)
Table 222. Latin America Avian Influenza Vaccines Sales by Country (2020-2025) & (M Doses)
Table 223. Latin America Avian Influenza Vaccines Sales by Country (2026-2031) & (M Doses)
Table 224. Latin America Avian Influenza Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 225. Latin America Avian Influenza Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 226. Latin America Avian Influenza Vaccines Sales by Type (2020-2025) & (M Doses)
Table 227. Latin America Avian Influenza Vaccines Sales by Application (2020-2025) & (M Doses)
Table 228. Middle East and Africa Avian Influenza Vaccines Sales by Country (2020-2025) & (M Doses)
Table 229. Middle East and Africa Avian Influenza Vaccines Sales by Country (2026-2031) & (M Doses)
Table 230. Middle East and Africa Avian Influenza Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 231. Middle East and Africa Avian Influenza Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 232. Middle East and Africa Avian Influenza Vaccines Sales by Type (2020-2025) & (M Doses)
Table 233. Middle East and Africa Avian Influenza Vaccines Sales by Application (2020-2025) & (M Doses)
Table 234. Avian Influenza Vaccines Key Raw Materials, Industry Status and Trend
Table 235. Avian Influenza Vaccines Key Raw Materials and Upstream Suppliers
Table 236. Avian Influenza Vaccines Clients Status and Trend
Table 237. Avian Influenza Vaccines Typical Clients
Table 238. Avian Influenza Vaccines Distributors
Table 239. Avian Influenza Vaccines Market Trends
Table 240. Avian Influenza Vaccines Market Drivers
Table 241. Avian Influenza Vaccines Market Challenges
Table 242. Avian Influenza Vaccines Market Restraints
Table 243. Research Programs/Design for This Report
Table 244. Key Data Information from Secondary Sources
Table 245. Key Data Information from Primary Sources
Table 246. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Avian Influenza Vaccines Product Picture
Figure 2. Global Avian Influenza Vaccines Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Avian Influenza Vaccines Sales Market Share by Type in 2024 & 2031
Figure 4. H5+H7 Avian Influenza Vaccines Product Picture
Figure 5. H9 Avian Influenza Vaccines Product Picture
Figure 6. Global Avian Influenza Vaccines Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Avian Influenza Vaccines Sales Market Share by Application in 2024 & 2031
Figure 8. Chicken
Figure 9. Duck & Goose
Figure 10. Other
Figure 11. Avian Influenza Vaccines Report Years Considered
Figure 12. Global Avian Influenza Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Avian Influenza Vaccines Market Size 2020-2031 (US$ Million)
Figure 14. Global Avian Influenza Vaccines Sales 2020-2031 (M Doses)
Figure 15. Global Avian Influenza Vaccines Sales Market Share Forecast by Region (2020-2031)
Figure 16. Global Avian Influenza Vaccines Revenue Market Share by Region (2020-2031)
Figure 17. Global Avian Influenza Vaccines Sales Market Share Forecast by Type (2020-2031)
Figure 18. Global Avian Influenza Vaccines Revenue Market Share Forecast by Type (2020-2031)
Figure 19. Avian Influenza Vaccines Average Selling Price (ASP) by Type (2020-2025) & (USD/K Doses)
Figure 20. Global Avian Influenza Vaccines Sales Market Share Forecast by Application (2020-2031)
Figure 21. Global Avian Influenza Vaccines Revenue Market Share Forecast by Application (2020-2031)
Figure 22. Avian Influenza Vaccines Average Selling Price (ASP) by Application (2020-2025) & (USD/K Doses)
Figure 23. H5+H7 Avian Influenza Vaccines of Avian Influenza Vaccines Revenue Market Share by Application, 2024 VS 2031
Figure 24. H9 Avian Influenza Vaccines of Avian Influenza Vaccines Revenue Market Share by Application, 2024 VS 2031
Figure 25. Global Avian Influenza Vaccines Sales Share by Manufacturer in 2024
Figure 26. Avian Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 27. H5+H7 Avian Influenza Vaccines Market Sales Proportion by Manufacturer in 2024
Figure 28. H9 Avian Influenza Vaccines Market Sales Proportion by Manufacturer in 2024
Figure 29. North America Avian Influenza Vaccines Revenue 2020-2031 (US$ Million)
Figure 30. North America Avian Influenza Vaccines Sales Market Share by Type (2020-2025)
Figure 31. North America Avian Influenza Vaccines Sales Market Share by Application (2020-2025)
Figure 32. Asia-Pacific Avian Influenza Vaccines Revenue 2020-2031 (US$ Million)
Figure 33. Asia-Pacific Avian Influenza Vaccines Sales Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Avian Influenza Vaccines Revenue Market Share by Region (2020-2031)
Figure 35. Asia-Pacific Avian Influenza Vaccines Sales Market Share by Type (2020-2025)
Figure 36. Asia-Pacific Avian Influenza Vaccines Sales Market Share by Application (2020-2025)
Figure 37. Europe Avian Influenza Vaccines Revenue Growth Rate 2020-2031 (US$ Million)
Figure 38. Europe Avian Influenza Vaccines Sales Market Share by Country (2020-2031)
Figure 39. Europe Avian Influenza Vaccines Revenue Market Share by Country (2020-2031)
Figure 40. Europe Avian Influenza Vaccines Sales Market Share by Type (2020-2025)
Figure 41. Europe Avian Influenza Vaccines Sales Market Share by Application (2020-2025)
Figure 42. Latin America Avian Influenza Vaccines Revenue Growth Rate 2020-2031 (US$ Million)
Figure 43. Latin America Avian Influenza Vaccines Sales Market Share by Country (2020-2031)
Figure 44. Latin America Avian Influenza Vaccines Revenue Market Share by Country (2020-2025)
Figure 45. Latin America Avian Influenza Vaccines Sales Market Share by Type (2020-2025)
Figure 46. Latin America Avian Influenza Vaccines Sales Market Share by Application (2020-2025)
Figure 47. Middle East and Africa Avian Influenza Vaccines Revenue Growth Rate 2020-2031 (US$ Million)
Figure 48. Middle East and Africa Avian Influenza Vaccines Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Avian Influenza Vaccines Revenue Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Avian Influenza Vaccines Sales Market Share by Type (2020-2025)
Figure 51. Middle East and Africa Avian Influenza Vaccines Sales Market Share by Application (2020-2025)
Figure 52. Avian Influenza Vaccines Supply Chain (Upstream and Downstream Market)
Figure 53. Global Production Market Share of Avian Influenza Vaccines Raw Materials by Region in 2024
Figure 54. Avian Influenza Vaccines Distribution Channels
Figure 55. Global Avian Influenza Vaccines Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 56. Global Avian Influenza Vaccines Percentage 2020-2031: Online Sales VS Offline Sales
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Trichosanthes Kirilowii Extract Market Research Report 2026
Feb 24, 26
Global Glass Lined Containers Market Research Report 2026
Feb 24, 26
Global Open End Wrenches Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232